Search results
Results from the Tech24 Deals Content Network
June 12, 2024 at 9:06 AM. Eli Lilly (LLY) is experiencing a banner year, as its stock price has reached new all-time highs in June. The surge comes on the heels of a series of positive ...
The bad news is that $15.35 divided into Lilly's $837 share price gives the stock a staggering 54.5 current-year P/E-- which is a lot for a pharma stock. (Pandemic era darling Pfizer for example ...
For a while, it seemed the streak was over for Eli Lilly (NYSE: LLY). Shares of the big drugmaker skyrocketed nearly 160% between early 2023 and mid-July of this year. However, Lilly's stock ...
In 1993, Randall L. Tobias, vice chairman of AT&T Corporation and a Lilly board member, was named Lilly's chairman, president, and CEO after "product and competitive pressures" had "steadily eroded Lilly's stock price since early 1992." [85] Tobias was the first president and CEO recruited from outside of the company.
Eli Lilly reported significantly better-than-expected earnings Thursday, with revenue coming in 13% higher than Wall Street estimates of $11.3 billion for the second quarter.That's a 36% jump in ...
One reason it's not too late to buy this stock is that Eli Lilly is making more money than it expected to at the start of the year. Management raised revenue guidance to a ceiling of $46.6 billion ...
How does Eli Lilly (NYSE: LLY) follow up on gains of close to 60% in 2023 and so far in 2024? By winning a major U.S. Food and Drug Administration (FDA) approval. Last week, the FDA approved Lilly ...
Eli Lilly’s share price has surged close to 700% over the past five years. Among its newer products are Mounjaro and Zepbound. Both medicines are from the increasingly popular class of drugs ...